Therapeutic potential of natural compounds in lung cancer

Journal article

Al-Yozbaki, M., Wilkin, P., Gupta, G. and Wilson, C. 2021. Therapeutic potential of natural compounds in lung cancer. Current Medicinal Chemistry. 28 (39), pp. 7988-8002. https://doi.org/10.2174/0929867328666210322103906
AuthorsAl-Yozbaki, M., Wilkin, P., Gupta, G. and Wilson, C.
AbstractLung cancer is a leading cause of cancer deaths worldwide. The management of lung cancer treatment is often ineffective as a result of the development of drug resistance, reactions to treatment, drug-drug interactions or non-specific targeting of the anticancer drugs. Natural compounds show promise and potential activity in lung cancer with very few side effects. While, the combinatorial action of an anti-cancer drug with a natural compound provides synergistic action which helps boost the overall therapeutic action against cancer cells. In cancer, there is a dysregulation of apoptosis which facilitates the cancer cell to survive, resulting in progression of cancer. Many cancer drugs cause mutations of genes that regulate cancer and should kill the cancer cell but lead to chemoresistance. There are many natural compounds that could specifically target different cell signalling pathways associated with cancer progression to provide a cytotoxic effect in the target cell. The importance of these compounds is emerging in many therapies developed with dual action often including a natural compound. In this review, we present a selection of these natural compounds and how they target lung cancer cells with a focus on the cell signalling pathways. Further work is required to delineate the potential action of natural compounds in the treatment against cancer.
KeywordsPharmacology; Molecular Medicine; Drug Discovery; Biochemistry; Organic Chemistry
Year2021
JournalCurrent Medicinal Chemistry
Journal citation28 (39), pp. 7988-8002
PublisherBentham Science Publishers
ISSN0929-8673
Digital Object Identifier (DOI)https://doi.org/10.2174/0929867328666210322103906
Official URLhttps://www.eurekaselect.com/node/192375/article/therapeutic-potential-of-natural-compounds-in-lung-cancer
Publication dates
Online22 Dec 2021
Print22 Dec 2021
Publication process dates
Accepted21 Mar 2021
Deposited30 Jul 2021
Accepted author manuscript
License
File Access Level
Open
Output statusPublished
Additional information

Publications router: Date 2021-12-22 of type 'publication_date' with format 'printed' included in notification
Publications router: Date 2021-12-22 of type 'ppub' included in notification
Publications router: Date 2021-12-22 of type 'issued' included in notification

Permalink -

https://repository.canterbury.ac.uk/item/8y4xw/therapeutic-potential-of-natural-compounds-in-lung-cancer

Download files

Accepted author manuscript
CMC 2021.pdf
License: CC BY-NC-ND 4.0
File access level: Open

  • 136
    total views
  • 216
    total downloads
  • 6
    views this month
  • 6
    downloads this month

Export as

Related outputs

Standard operating procedure for the operation of SEM-EDX for elemental analysis, with additional applications to biomass
Hernandez, E., Thomas, J.K., Kheirandish, K., Wilson, C. and Ortega, H. 2024. Standard operating procedure for the operation of SEM-EDX for elemental analysis, with additional applications to biomass. Canterbury Christ Church University. https://doi.org/10.5281/zenodo.13736742
Differential microRNA expression in the SH-SY5Y human cell model as potential biomarkers for Huntington’s disease
Belkozhayev, Ayaz, Niyazova, Raigul, Kamal, Mohammad Amjad, Ivashchenko, Anatoliy, Sharipov, Kamalidin and Wilson, C. 2024. Differential microRNA expression in the SH-SY5Y human cell model as potential biomarkers for Huntington’s disease. Frontiers in Cellular Neuroscience. 18, p. 1399742. https://doi.org/10.3389/fncel.2024.1399742
Novel transcriptional and DNA methylation abnormalities of SORT1 Gene in non-small cell lung cancer
Acha-Sagredo, Amelia, Wilson, C., Garcia Bediaga, Naiara, Kalirai, Helen, Davies, M., Coupland, S., Field, John K and Liloglou, T. 2024. Novel transcriptional and DNA methylation abnormalities of SORT1 Gene in non-small cell lung cancer. Cancers. 16 (11), p. 2154. https://doi.org/10.3390/cancers16112154
Editorial: Targeting nucleotide metabolism for enhancing antitumor immunity.
Wu, Jun, Rong, Yu, Li, Tian, Wilson, C., He, Yazhou, Chen, Danqian, Han, Jin and Zhang, Xingmei 2024. Editorial: Targeting nucleotide metabolism for enhancing antitumor immunity. Frontiers in Immunology. 15, p. 1412057. https://doi.org/10.3389/fimmu.2024.1412057
Investigating the effect of mesoporous silica nanoparticles as a drug delivery system for Withaferin A in the treatment of Lung Cancer
Holder, J., Wilson, C., Bertolo-Pardo, E., Byrne, L., Lodeiro, C., Oliveira, E. and Trim, C. 2024. Investigating the effect of mesoporous silica nanoparticles as a drug delivery system for Withaferin A in the treatment of Lung Cancer.
Investigating the effect of silica nanoparticles as a drug delivery system for Doxorubicin in the treatment of lung cancer
Holder, J., Wilson, C., Bertolo-Pardo, E., Byrne, L., Oliveira, E., Lodeiro, C. and Trim, C. 2024. Investigating the effect of silica nanoparticles as a drug delivery system for Doxorubicin in the treatment of lung cancer.
AI is a viable alternative to high throughput screening: a 318-target study
Wilson, C.M., Byrne, L., Al-Yozbaki, M. and The Atomwise AIMS Program 2024. AI is a viable alternative to high throughput screening: a 318-target study. Scientific Reports. https://doi.org/10.1038/s41598-024-54655-z
Mesenchymal stem cell-derived exosomes: Characteristics and applications in disease pathology and management.
Padinharayil, H., Varghese, J., Wilson, C. and George, A. 2024. Mesenchymal stem cell-derived exosomes: Characteristics and applications in disease pathology and management. Life Sciences. 342 (122542). https://doi.org/10.1016/j.lfs.2024.122542
Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options.
Panneerselvam, S., Wilson, Cornelia, Kumar, Prem, Abirami, Dinu, Pamarthi, Jayakrishna, Reddy, Mettu Srinivas and Varghese, Joy 2023. Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options. Cell Adhesion and Migration. 17 (1), pp. 1-21. https://doi.org/10.1080/19336918.2023.2258539
The use of nanoparticles for targeted drug delivery in non-small cell lung cancer.
Holder, Jessica E, Ferguson, C., Oliveira, Elisabete, Lodeiro, Carlos, Trim, Carol M, Byrne, Lee J, Bertolo, Emilia and Wilson, Cornelia M 2023. The use of nanoparticles for targeted drug delivery in non-small cell lung cancer. Frontiers in Oncology. 13, p. 1154318. https://doi.org/10.3389/fonc.2023.1154318
The role of nanotechnology for diagnostic and therapy strategies in lung cancer
Holder, J., Wilson, C. and Al-Yozbaki, M. 2022. The role of nanotechnology for diagnostic and therapy strategies in lung cancer. in: Jeremić, B. (ed.) Advances in Radiation Oncology in Lung Cancer Cham Springer.
Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics.
Padinharayil, Hafiza, Varghese, Jinsu, John, Mithun Chacko, Rajanikant, Golgodu Krishnamurthy, Wilson, Cornelia M, Al-Yozbaki, Minnatallah, Renu, Kaviyarasi, Dewanjee, Saikat, Sanyal, Rupa, Dey, Abhijit, Mukherjee, Anirban Goutam, Wanjari, Uddesh Ramesh, Gopalakrishnan, Abilash Valsala and George, Alex 2022. Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics. Genes & Diseases. 10 (3), pp. 960-989. https://doi.org/10.1016/j.gendis.2022.07.023
The role of nanotechnology for diagnostic and therapy strategies in lung cancer
Holder, J., Al-Yozbaki, M. and Wilson, C. 2022. The role of nanotechnology for diagnostic and therapy strategies in lung cancer. in: Medical Radiology Berlin, Heidelberg Springer. pp. 1-18
Advances in the lung cancer immunotherapy approaches
Padinharayil, H., Alappat, R., Joy, Liji Maria, Anilkumar, K., Wilson, C., George, A., Valsala Gopalakrishnan, A., Madhyastha, H., Ramesh, Thiyagarajan, Sathiyamoorthi, Ezhaveni, Lee, Jintae and Ganesan, R. 2022. Advances in the lung cancer immunotherapy approaches. Vaccines. 10 (11), p. 1963. https://doi.org/10.3390/vaccines10111963
Proteomic analysis of the extracellular vesicles derived from human hip joints affected by osteoarthritis
Tirnoveanu, A., Ahmed, S., Webb, R., Howland, K., Hurt, A., Wilson, C. and Mylona, A. 2022. Proteomic analysis of the extracellular vesicles derived from human hip joints affected by osteoarthritis.
Bioinformatics analysis of the interaction of miRNAs and piRNAs with human mRNA genes having di- and Trinucleotide repeats
Belkozhayev, A., Niyazova, Raigul, Wilson, C., Jainakbayev, Nurlan, Pyrkova, A., Ashirbekov, Y., Akimniyazova, A., Sharipov, K. and Ivashchenko, A. 2022. Bioinformatics analysis of the interaction of miRNAs and piRNAs with human mRNA genes having di- and Trinucleotide repeats. Genes. 13 (5), p. 800. https://doi.org/10.3390/genes13050800
Stochastic variation in DNA methylation modulates nucleosome occupancy and alternative splicing in Arabidopsis thaliana
Jabre, Ibtissam, Chaudhary, S., Wilson, C., Staiger, D. and Syed, N. 2022. Stochastic variation in DNA methylation modulates nucleosome occupancy and alternative splicing in Arabidopsis thaliana. Plants. 11 (9), p. 1105. https://doi.org/10.3390/plants11091105
Extracellular vesicles, stem cells and the role of miRNAs in neurodegeneration
Belkozhayev, Ayaz M., Al-Yozbaki, Minnatallah, George, Alex, Ye Niyazova, Raigul, Sharipov, Kamalidin O., Byrne, Lee J. and Wilson, Cornelia M. 2021. Extracellular vesicles, stem cells and the role of miRNAs in neurodegeneration. Current Neuropharmacology. 20 (8), pp. 1450-1478. https://doi.org/10.2174/1570159x19666210817150141
Exploring the cytotoxic mechanisms of Pediocin PA-1 towards HeLa and HT29 cells by comparison to known bacteriocins: Microcin E492, enterocin heterodimer and Divercin V41.
Buss, G. and Wilson, C. 2021. Exploring the cytotoxic mechanisms of Pediocin PA-1 towards HeLa and HT29 cells by comparison to known bacteriocins: Microcin E492, enterocin heterodimer and Divercin V41. PLoS ONE. 16 (9), p. e0251951. https://doi.org/10.1371/journal.pone.0251951
The undiscovered potential of essential oils for treating SARS-CoV-2 (COVID-19)
Wilkin, P. J., Al-Yozbaki, M., George, A., Gupta, G.K. and Wilson, C.M. 2021. The undiscovered potential of essential oils for treating SARS-CoV-2 (COVID-19). Current Pharmaceutical Design. 26 (41), pp. 5261-5277. https://doi.org/10.2174/1381612826666201015154611
Balancing neurotrophin pathway and sortilin function: its role in human disease
Al-Yozbaki, M., Acha-Sagredo, A., George, A., Liloglou, T. and Wilson, C.M. 2021. Balancing neurotrophin pathway and sortilin function: its role in human disease. Biochim Biophys Acta Rev Cancer. 1874 (2). https://doi.org/10.1016/j.bbcan.2020.188429
Targeting DNA methyltransferases in non-small-cell lung cancer
Al-Yozbaki, M., Jabre, I., Syed, N. and Wilson, C. 2021. Targeting DNA methyltransferases in non-small-cell lung cancer. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2021.01.005
Differential nucleosome occupancy modulates alternative splicing in Arabidopsis thaliana
Jabre, I., Chaudhary, S., Guo, W., Kalyna, M., Reddy, A. S. N., Chen, W., Zhang, R., Wilson, C. and Syed, N. 2020. Differential nucleosome occupancy modulates alternative splicing in Arabidopsis thaliana. New Phytologist. https://doi.org/10.1111/nph.17062
Applications and strategies in nanodiagnosis and nanotherapy in lung cancer
Woodman, C., Vundu, G., George, A. and Wilson, C. 2020. Applications and strategies in nanodiagnosis and nanotherapy in lung cancer. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2020.02.009
The role of endoproteolytic processing in neurodegeneration
Wilson, C., Mushtaq, G., Kamal, M. and Terro, F. 2016. The role of endoproteolytic processing in neurodegeneration. CNS and Neurological Disorders Drug Targets. 15. https://doi.org/10.2174/1871527315666160922163511
Challenges and strategies in precision medicine for non-small cell lung cancer
Wilson, C., Al-Akhrass, A. and Sacco, J. 2016. Challenges and strategies in precision medicine for non-small cell lung cancer. Current Pharmaceutical Design. 22. https://doi.org/10.2174/1381612822666160603014932
Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors
Wilson, C., Naves, T., Vincent, F., Lalloue, F. and Jauberteau, M. 2015. Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors.
Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors.
Wilson, C., Naves, T., Vincent, F., Melloni, B., Bonnaud, F., Lalloue, F. and Jauberteau, M. 2014. Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors. Journal of Cell Science (JCS). 127 (18), pp. 3983-3997. https://doi.org/10.1242/jcs.149336